Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Ureteral Neoplasms × Practice Guidelines as Topic × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Urinary Bladder Neoplasms 2 Rectal Neoplasms 2 Neoplasms 2 Colorectal Neoplasms 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Recurrence 1 Radiodermatitis 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Multiple Endocrine Neoplasia Type 1 1 Melanoma 1 Lung Neoplasms 1 Localized Prostate Carcinoma 1 Leukemia, Myeloid, Acute 1 Hepatitis B 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1 Esophageal Neoplasms 1 Endometrial Clear Cell Adenocarcinoma 1 Disease Progression 1 Digestive System Carcinoma 1 Communication 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

Gemcitabine 5 Cisplatin 4 enfortumab vedotin 2 Ramucirumab 2 Platinum 2 Docetaxel 2 1,2-diaminocyclohexaneplatinum II citrate 2 vinflunine 1 rucaparib 1 pembrolizumab 1 eribulin 1 enzalutamide 1 dehydroftorafur 1 carotuximab 1 avelumab 1 atezolizumab 1 Standard of Care 1 Specimen Handling 1 Radiotherapy 1 Radiation 1 Paclitaxel 1 N-(3-aminopropyl)-N-(1-(5-benzyl-3-methyl-4-oxo-(1,2)thiazolo(5,4-d)pyrimidin-6-yl)-2-methylpropyl)-4-methylbenzamide 1 Mitozytrex 1 Mitomycin 1 Magnetic Resonance Spectroscopy 1 Interleukin-7 1 Immunoglobulin G 1 Icrucumab 1 IMC-18F1 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡